# Effects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIAD

> **NCT06277336** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 15 (actual)

## Conditions studied

- SIAD - Syndrome of Inappropriate Antidiuresis
- Hyponatremia

## Interventions

- **DRUG:** Placebo
- **DRUG:** Apelin Low Dose
- **DRUG:** Apelin High Dose
- **DRUG:** Selected Apelin Dose

## Key facts

- **NCT ID:** NCT06277336
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-01
- **Primary completion:** 2025-03-18
- **Final completion:** 2025-03-18
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06277336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06277336, "Effects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIAD". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06277336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*